Michael Weintraub, MD, and Veena K. Ranganath, MD, MS, RhMSUS, will discuss the evolving landscape of glucagon-like peptide-1 receptor agonists and current evidence for the use of this kind of incretin therapy in rheumatologic diseases.
In two lectures across two days, Varitka Kesarwani, MBBS, will review the mechanisms of immunology to help attendees build a mental framework they can leverage in the clinic.
ABSTRACT: Hilbert Nguyen, PT, DPT
Experts will provide an overview of the immunobiology of cellular therapies for rheumatic diseases, examine which diseases might be most responsive to these therapies, share results from recent clinical trials, and debate the correct pace for the widespread use of cellular therapy in rheumatology.
ABSTRACT: Ann-Christin Pecher, MD